JP2021500078A5 - - Google Patents

Download PDF

Info

Publication number
JP2021500078A5
JP2021500078A5 JP2020542716A JP2020542716A JP2021500078A5 JP 2021500078 A5 JP2021500078 A5 JP 2021500078A5 JP 2020542716 A JP2020542716 A JP 2020542716A JP 2020542716 A JP2020542716 A JP 2020542716A JP 2021500078 A5 JP2021500078 A5 JP 2021500078A5
Authority
JP
Japan
Prior art keywords
composition
cells
sortilin
peptide
diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020542716A
Other languages
English (en)
Japanese (ja)
Other versions
JP7438119B2 (ja
JP2021500078A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/057016 external-priority patent/WO2019083944A2/en
Publication of JP2021500078A publication Critical patent/JP2021500078A/ja
Publication of JP2021500078A5 publication Critical patent/JP2021500078A5/ja
Application granted granted Critical
Publication of JP7438119B2 publication Critical patent/JP7438119B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020542716A 2017-10-23 2018-10-23 細胞外小胞関連疾患のための材料および方法 Active JP7438119B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762575762P 2017-10-23 2017-10-23
US62/575,762 2017-10-23
PCT/US2018/057016 WO2019083944A2 (en) 2017-10-23 2018-10-23 MATERIALS AND METHODS FOR DISEASES ASSOCIATED WITH EXTRACELLULAR VESICLES

Publications (3)

Publication Number Publication Date
JP2021500078A JP2021500078A (ja) 2021-01-07
JP2021500078A5 true JP2021500078A5 (https=) 2021-10-14
JP7438119B2 JP7438119B2 (ja) 2024-02-26

Family

ID=66247653

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020542716A Active JP7438119B2 (ja) 2017-10-23 2018-10-23 細胞外小胞関連疾患のための材料および方法

Country Status (3)

Country Link
US (2) US11833187B2 (https=)
JP (1) JP7438119B2 (https=)
WO (1) WO2019083944A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3280441T1 (sl) 2015-04-07 2022-01-31 Alector Llc Protitelesa anti-sortilin in metoda njihove uporabe
LT3618928T (lt) 2018-07-13 2023-04-11 Alector Llc Anti-sortilino antikūnai ir jų panaudojimo būdai

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008076262A2 (en) 2006-12-15 2008-06-26 Merck & Co., Inc. Receptor for amyloid beta and uses thereof
RS60019B1 (sr) 2006-12-21 2020-04-30 H Lundbeck As Modulacija aktivnosti proneurotrofina
KR101614558B1 (ko) 2008-04-27 2016-04-22 하. 룬드벡 아크티에셀스카브 인간 소르틸린의 결정 구조 및 소르틸린에 대한 리간드를 확인하기 위한 이의 용도
WO2009132655A2 (en) 2008-04-27 2009-11-05 H. Lundbeck A/S Design and use of sortilin specific molecular imaging ligands
EP2440233B1 (en) 2009-06-10 2016-07-13 Aarhus Universitet Sorcs1-like agent for use in the treatment of insulin resistance and diseases related thereto
WO2016164608A1 (en) 2015-04-07 2016-10-13 Alector Llc Methods of screening for sortilin binding antagonists
SI3280441T1 (sl) 2015-04-07 2022-01-31 Alector Llc Protitelesa anti-sortilin in metoda njihove uporabe

Similar Documents

Publication Publication Date Title
Anthis et al. β integrin tyrosine phosphorylation is a conserved mechanism for regulating talin-induced integrin activation
Sun et al. Hrs regulates early endosome fusion by inhibiting formation of an endosomal SNARE complex
Russo et al. Characterization of the β-dystroglycan–growth factor receptor 2 (Grb2) interaction
KR101758671B1 (ko) 올리고펩타이드 화합물 및 이의 용도
JP2023503653A5 (https=)
Heikkinen et al. Collagen XIII: a type II transmembrane protein with relevance to musculoskeletal tissues, microvessels and inflammation
CN104130315B (zh) 一种特异靶向her2蛋白的多肽
Spener et al. Characteristics of fatty acid-binding proteins and their relation to mammary-derived growth inhibitor
JP2013542182A (ja) 化合物及び方法
Yano et al. Live-cell imaging of membrane proteins by a coiled-coil labeling method—Principles and applications
US8586708B2 (en) Monovalent streptavidin compositions
Hubstenberger et al. Topological analysis of ATAD3A insertion in purified human mitochondria
JP2021500078A5 (https=)
CN106715709A (zh) 用于调节mTORC1的组合物和方法
KR101636882B1 (ko) 인간 피브로넥틴 도메인 Ⅲ 기본 골격의 신규 인간 ＥｐｈＡ2 특이적 결합 단백질 및 그의 용도
CN106188270A (zh) Rhamm结合肽
JP5765688B2 (ja) アクチン結合タンパク質の細胞運動関連疾患への利用
US20070105162A1 (en) Monovalent avidin and streptavidin compositions
JP2009502732A5 (https=)
Hayashi et al. High affinity receptor labeling based on basic leucine zipper domain peptides conjugated with pH-sensitive fluorescent dye: visualization of AMPA-type glutamate receptor endocytosis in living neurons
Shibata et al. Molecular cloning and characterization of rat brain endothelial cell derived gene-1 (tumor suppressor candidate 5) expressing abundantly in adipose tissues
US11034728B2 (en) Peptides for binding epidermal growth factor
JP6653504B2 (ja) ミッドカイン結合性ペプチドアプタマーおよびその使用
WO2021021811A2 (en) Myosin derived peptides and related compounds with anticoagulant activities
US12595289B2 (en) Therapeutic agent for breast cancer comprising BIG3-PHB2 interaction-inhibiting peptide derived from PHB2